Literature DB >> 26120935

PI3K Phosphorylation Is Linked to Improved Electrical Excitability in an In Vitro Engineered Heart Tissue Disease Model System.

Kujaany Kana1, Hannah Song1, Carol Laschinger2, Peter W Zandstra1,3,4, Milica Radisic1,2,3.   

Abstract

Myocardial infarction, a prevalent cardiovascular disease, is associated with cardiomyocyte cell death, and eventually heart failure. Cardiac tissue engineering has provided hopes for alternative treatment options, and high-fidelity tissue models for drug discovery. The signal transduction mechanisms relayed in response to mechanoelectrical (physical) stimulation or biochemical stimulation (hormones, cytokines, or drugs) in engineered heart tissues (EHTs) are poorly understood. In this study, an EHT model was used to elucidate the signaling mechanisms involved when insulin was applied in the presence of electrical stimulation, a stimulus that mimics functional heart tissue environment in vitro. EHTs were insulin treated, electrically stimulated, or applied in combination (insulin and electrical stimulation). Electrical excitability parameters (excitation threshold and maximum capture rate) were measured. Protein kinase B (AKT) and phosphatidylinositol-3-kinase (PI3K) phosphorylation revealed that insulin and electrical stimulation relayed electrical excitability through two separate signaling cascades, while there was a negative crosstalk between sustained activation of AKT and PI3K.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26120935      PMCID: PMC4559196          DOI: 10.1089/ten.TEA.2014.0412

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  48 in total

1.  Development of a drug screening platform based on engineered heart tissue.

Authors:  Arne Hansen; Alexandra Eder; Marlene Bönstrup; Marianne Flato; Marco Mewe; Sebastian Schaaf; Bülent Aksehirlioglu; Alexander P Schwoerer; Alexander Schwörer; June Uebeler; Thomas Eschenhagen
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

2.  Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes.

Authors:  Hoi Ting H Au; Irene Cheng; Mohammad F Chowdhury; Milica Radisic
Journal:  Biomaterials       Date:  2007-07-02       Impact factor: 12.479

3.  PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury.

Authors:  Tomohisa Nagoshi; Takashi Matsui; Takuma Aoyama; Annarosa Leri; Piero Anversa; Ling Li; Wataru Ogawa; Federica del Monte; Judith K Gwathmey; Luanda Grazette; Brian A Hemmings; Brian Hemmings; David A Kass; Hunter C Champion; Anthony Rosenzweig
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

4.  Factors affecting the activation of glycogen synthase in primary culture cardiomyocytes.

Authors:  S R Jaspers; A K Garnache; T B Miller
Journal:  J Mol Cell Cardiol       Date:  1993-10       Impact factor: 5.000

Review 5.  Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview.

Authors:  Christine L Mummery; Jianhua Zhang; Elizabeth S Ng; David A Elliott; Andrew G Elefanty; Timothy J Kamp
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

6.  PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.

Authors:  Ruby C Y Lin; Kate L Weeks; Xiao-Ming Gao; Rohan B H Williams; Bianca C Bernardo; Helen Kiriazis; Vance B Matthews; Elizabeth A Woodcock; Russell D Bouwman; Janelle P Mollica; Helen J Speirs; Ian W Dawes; Roger J Daly; Tetsuo Shioi; Seigo Izumo; Mark A Febbraio; Xiao-Jun Du; Julie R McMullen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04       Impact factor: 8.311

7.  Exercise improves the dilatation function of mesenteric arteries in postmyocardial infarction rats via a PI3K/Akt/eNOS pathway-mediated mechanism.

Authors:  Youhua Wang; Shengpeng Wang; W Gil Wier; Quanjiang Zhang; Hongke Jiang; Qiuxia Li; Shengfeng Chen; Zhenjun Tian; Youyou Li; Xiaojiang Yu; Ming Zhao; Jinjun Liu; Jing Yang; Jing Zhang; Weijin Zang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

8.  Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt.

Authors:  Young-Kwon Kim; Song-Jung Kim; Atsuko Yatani; Yanhong Huang; Germana Castelli; Dorothy E Vatner; Jing Liu; Qizhi Zhang; Gissela Diaz; Renata Zieba; Jill Thaisz; Alessandra Drusco; Carlo Croce; Junichi Sadoshima; Gianluigi Condorelli; Stephen F Vatner
Journal:  J Biol Chem       Date:  2003-09-16       Impact factor: 5.157

9.  Phosphoinositide 3-kinase regulates excitation-contraction coupling in neonatal cardiomyocytes.

Authors:  Susan A McDowell; Eileen McCall; William F Matter; Thomas B Estridge; Chris J Vlahos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-10-16       Impact factor: 4.733

10.  2D and 3D-organized cardiac cells shows differences in cellular morphology, adhesion junctions, presence of myofibrils and protein expression.

Authors:  Carolina Pontes Soares; Victor Midlej; Maria Eduarda Weschollek de Oliveira; Marlene Benchimol; Manoel Luis Costa; Cláudia Mermelstein
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more
  1 in total

Review 1.  ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.

Authors:  Rosalinda Madonna; Linda W Van Laake; Hans Erik Botker; Sean M Davidson; Raffaele De Caterina; Felix B Engel; Thomas Eschenhagen; Francesco Fernandez-Aviles; Derek J Hausenloy; Jean-Sebastien Hulot; Sandrine Lecour; Jonathan Leor; Philippe Menasché; Maurizio Pesce; Cinzia Perrino; Fabrice Prunier; Sophie Van Linthout; Kirsti Ytrehus; Wolfram-Hubertus Zimmermann; Peter Ferdinandy; Joost P G Sluijter
Journal:  Cardiovasc Res       Date:  2019-03-01       Impact factor: 10.787

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.